Align Technology, Inc. ALGN

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

The global dental equipment market is projected to grow from USD 8.31 billion in 2026 to USD 11.48 billion by 2031, registering a 5.5% CAGR. Growth is driven by rising oral health disorders, demand for cosmetic and preventive dentistry, dental tourism, and adoption of digital imaging, CAD/CAM, intraoral scanners, laser dentistry, and 3D printing. Therapeutic dental equipment will hold the largest market share, while hospitals and clinics remain the leading end users. The US is expected to record

TEMPE, Ariz., September 28, 2026--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the launch of SHIFT Happens, a new consumer campaign designed to help Invisalign-trained doctors connect with and educate adult consumers about lifelong tooth movement and explain the

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Align Technology has lagged the broader market over the past year, even as Wall Street analysts remain cautiously optimistic about the company’s future prospects.

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

TEMPE, Ariz., September 08, 2026--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following financial conference. The presentation will be webcast live via the Investor Relations section of Align's website at

Align Technology stock has delivered a steeply negative 5 year share price performance, yet current valuation checks suggest the market price may now be below what its cash flows imply. At the same time, traditional market multiples look roughly in line with peers, which leaves investors weighing an intrinsic value signal that points to a discount against a share price that does not screen as extreme on earnings based measures. Over the past 5 years, Align Technology shares have declined...

Align Technology (NasdaqGS:ALGN) appoints Quentin Blackford of iRhythm Technologies to its board of directors. Andrea L. Saia plans to resign from Align Technology's board after serving for more than a decade. The board change introduces new operating and strategy experience as Align Technology marks the end of Saia's long tenure during its growth as a digital dentistry leader. For investors tracking how leadership shifts can influence long term direction, it can be useful to compare Align...

Align Technology (ALGN) is back in focus after its latest earnings report, which met revenue expectations and exceeded earnings forecasts, while also including softer guidance amid pricing and economic pressures across the sector. Align Technology’s recent guidance weighed on sentiment, and the stock has fallen about 12% since the earnings release. This contributed to a 9.26% decline in the 30 day share price return, even though the 1 year total shareholder return of 14.03% remains positive...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.